In the present study, we investigated the transcriptional expression profiles of BDKRB2 in 998 glioma patients and revealed that BDKRB2 expression showed a significantly positive correlation with the WHO grade of glioma. The gene discussed is BDKRB2; the disease is central nervous system cancer.